David Taber to Drug Monitoring
This is a "connection" page, showing publications David Taber has written about Drug Monitoring.
Connection Strength
2.880
-
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):776-784.
Score: 0.689
-
Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. Ann Pharmacother. 2020 12; 54(12):1185-1193.
Score: 0.648
-
Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149.
Score: 0.609
-
Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017 Sep 01; 74(17 Supplement 3):S67-S74.
Score: 0.535
-
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy. 2021 01; 41(1):119-131.
Score: 0.168
-
Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Exp Clin Transplant. 2019 12; 17(6):707-713.
Score: 0.146
-
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left?Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778.
Score: 0.037
-
Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Am J Health Syst Pharm. 2012 Nov 15; 69(22):1993-8.
Score: 0.024
-
Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
Score: 0.023